The Latest Cardiac and Vascular News
KIRKLAND, Wash.–(BUSINESS WIRE)–You love the outdoors – but your heart might not. If you enjoy skiing, hiking and other sports experienced at high altitudes, you might be well advised to spend your first day at altitude taking it easy. In older men, especially those unaccustomed to intense physical exertion and […]
Santa Monica, CA, Aug. 22, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that it has been selected to present at the third annual […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced that it will present at the Morgan Stanley Global Healthcare Conference at the Grand Hyatt Hotel in New York on Friday, September 14, 2018. Management is scheduled to present […]
SOUTHLAKE, Texas–(BUSINESS WIRE)–HeartSciences, a medical device company developing next generation ECG devices using continuous wavelet transform (CWT) signal processing and artificial intelligence, is proud to announce its participation as an exhibitor at the upcoming 2018 European Society of Cardiology Congress (ESC). The Congress will take place at Messe Munich International […]
NGELHEIM, Germany–(BUSINESS WIRE)–Boehringer Ingelheim today announced that it will present nine sub-analyses from the RE-DUAL PCITM trial and GLORIATM-AF Registry Program at the upcoming ESC Congress 2018, organised by the European Society of Cardiology, taking place in Munich, Germany on the 25-29 August 2018. The primary data from these studies have contributed […]
MUNICH, August 20, 2018 /PRNewswire/ — Satellite symposium will highlight the breadth of evidence collected since the establishment of the registry in2009 An analysis of the comparative effectiveness of oral anticoagulants in everyday practice will be presented The economic burden of atrial fibrillation (AF) in nine European countries will be evaluated The […]
WASHINGTON, Aug. 16, 2018 /PRNewswire/ — An article published in Experimental Biology and Medicine (Volume 243, Issue 11, July, 2018) (http://journals.sagepub.com/doi/pdf/10.1177/1535370218788517) reports that the antiarrhythmic drug, dronedarone, promotes cardiac repair after a heart attack. The study, led by Dr. Uwe Lendeckel, Professor for Medical Biochemistry and Molecular Biology at the University Medicine Greifswald, provides mechanistic […]
VANCOUVER, Aug. 16, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients, today reported positive data highlighting reduced hospitalization in patients treated with Brinavess® (vernakalant hydrochloride, IV), its antiarrhythmic drug for the […]
BRADENTON, Fla.–(BUSINESS WIRE)–PaceMate™ is pleased to announce that as of August 15, 2018, the Arizona Heart Rhythm Center will be the first organization in the state of Arizona to offer automated remote monitoring of cardiac implantable electronic devices (CIEDs) such as pacemakers, defibrillators, and loop recorders via the PaceMate™ software […]
Santa Monica, CA, Aug. 14, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM), announced that the Company has received 510(k) clearance for its first product, PURE EP System, from the U.S. Food and Drug Administration (FDA). The non-invasive PURE EP System is a computerized system intended for acquiring, digitizing, amplifying, filtering, measuring […]
